Total Payments
$16,777
2024 Payments
$2,339
Companies
38
Transactions
1,076
Medicare Patients
4,034
Medicare Billing
$390,582
Payment Breakdown by Category
Food & Beverage$16,410 (97.8%)
Education$266.93 (1.6%)
Gifts$100.00 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,410 | 1,071 | 97.8% |
| Education | $266.93 | 4 | 1.6% |
| Gift | $100.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,028 | 216 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,017 | 330 | $0 (2024) |
| Janssen Biotech, Inc. | $2,637 | 156 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $780.85 | 49 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $680.56 | 35 | $0 (2017) |
| IRONWOOD PHARMACEUTICALS, INC | $456.87 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $421.02 | 25 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $409.88 | 23 | $0 (2023) |
| Gilead Sciences, Inc. | $382.17 | 18 | $0 (2024) |
| QOL Medical, LLC | $325.02 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,339 | 131 | ABBVIE INC. ($947.38) |
| 2023 | $2,509 | 139 | AbbVie Inc. ($791.73) |
| 2022 | $2,913 | 189 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($708.75) |
| 2021 | $2,359 | 180 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($622.12) |
| 2020 | $864.12 | 64 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($259.14) |
| 2019 | $2,088 | 136 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($781.91) |
| 2018 | $1,857 | 123 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($703.82) |
| 2017 | $1,848 | 114 | Valeant Pharmaceuticals North America LLC ($680.56) |
All Payment Transactions
1,076 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: LIVER DISEASE | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.05 | General |
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,028 | 3,157 | $376,803 | $102,185 |
| 2022 | 16 | 985 | 2,760 | $310,560 | $96,758 |
| 2021 | 15 | 983 | 1,097 | $318,519 | $98,464 |
| 2020 | 18 | 1,038 | 3,288 | $343,422 | $93,174 |
Total Patients
4,034
Total Services
10,302
Medicare Billing
$390,582
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 271 | $34,417 | $21,624 | 62.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 94 | 96 | $80,450 | $17,609 | 21.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 157 | 162 | $68,844 | $9,463 | 13.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 113 | 113 | $80,107 | $9,134 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $13,386 | $7,317 | 54.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 47 | 48 | $24,058 | $4,927 | 20.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 27 | 27 | $16,200 | $4,575 | 28.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 18 | 19 | $8,322 | $4,069 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 68 | $6,460 | $3,812 | 59.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 55 | 146 | $9,782 | $3,478 | 35.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 28 | 71 | $6,532 | $3,353 | 51.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $6,344 | $3,278 | 51.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 24 | 40 | $4,480 | $2,366 | 52.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 23 | 26 | $4,550 | $2,193 | 48.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 35 | $3,045 | $2,026 | 66.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $6,112 | $1,438 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $2,667 | $1,316 | 49.4% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 23 | 1,903 | $1,047 | $208.70 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 308 | $39,116 | $25,039 | 64.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 91 | 91 | $75,894 | $16,958 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 198 | $18,810 | $10,530 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $15,520 | $8,404 | 54.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 94 | 96 | $40,128 | $6,048 | 15.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 77 | 77 | $50,743 | $5,818 | 11.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 16 | 17 | $7,446 | $3,893 | 52.3% |
About Dr. Meredith Roath, M.D
Dr. Meredith Roath, M.D is a Gastroenterology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497947949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meredith Roath, M.D has received a total of $16,777 in payments from pharmaceutical and medical device companies, with $2,339 received in 2024. These payments were reported across 1,076 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($16,410).
As a Medicare-enrolled provider, Roath has provided services to 4,034 Medicare beneficiaries, totaling 10,302 services with total Medicare billing of $390,582. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Huntsville, AL
- Active Since 08/17/2007
- Last Updated 09/25/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497947949
Products in Payments
- XIFAXAN (Drug) $2,738
- STELARA (Biological) $2,661
- RINVOQ (Biological) $915.84
- LINZESS (Drug) $856.14
- TRULANCE (Drug) $727.38
- SKYRIZI (Biological) $704.50
- DUPIXENT (Biological) $496.05
- ENTYVIO (Biological) $490.79
- DIFICID (Drug) $421.02
- HUMIRA (Biological) $408.54
- Humira (Biological) $404.99
- APRISO (Drug) $402.16
- Linzess (Drug) $346.26
- Mavyret (Drug) $322.11
- RELISTOR (Drug) $321.87
- ZENPEP (Drug) $264.31
- Sucraid (Drug) $231.34
- MAVYRET (Drug) $227.76
- MOVIPREP (Drug) $200.81
- OCALIVA (Drug) $197.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Huntsville
Michael Dohrenwend, Md, MD
Gastroenterology — Payments: $48,133
Gastroenterology $48,133
John-Paul Voelkel, M.d, M.D
Gastroenterology — Payments: $17,351
Gastroenterology $17,351
Charles Billings, Md, MD
Gastroenterology — Payments: $16,031
Gastroenterology $16,031
Dino Ferrante, Md, MD
Gastroenterology — Payments: $15,843
Gastroenterology $15,843
Mark Moglowsky, Md, MD
Gastroenterology — Payments: $12,186
Gastroenterology $12,186
Suresh Karne, Md Phd, MD PHD
Gastroenterology — Payments: $11,520
Gastroenterology $11,520